Fulgent Genetics, Inc. (FLGT) › RevenueFulgent Genetics, Inc. (FLGT) — RevenueAnnual figures by period end, from SEC filings.2017-12-31: $18.73M2018-12-31: $21.35M2019-12-31: $32.53M2020-12-31: $421.71M2021-12-31: $992.58M2022-12-31: $618.97M2023-12-31: $289.21M2024-12-31: $283.47M2025-12-31: $322.67M$322.67M2017-12-31Revenue (USD)2025-12-31Period endedRevenueChange YoYSource filing2025-12-31$322.67M+13.8%2026-02-27From 2025-01-012024-12-31$283.47M-2.0%2026-02-27From 2024-01-012023-12-31$289.21M-53.3%2026-02-27From 2023-01-012022-12-31$618.97M-37.6%2025-02-28From 2022-01-012021-12-31$992.58M+135.4%2024-02-28From 2021-01-012020-12-31$421.71M+1196.5%2023-02-28From 2020-01-012019-12-31$32.53M+52.3%2022-02-28From 2019-01-012018-12-31$21.35M+14.0%2020-03-13From 2018-01-012017-12-31$18.73M—2019-03-22From 2017-01-01Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)